This result aligns with findings in human breast carcinoma cell lines, where ADAMTS-9 has been downregulated in malignant and invasive breast carcinomas compared to non-neoplastic ones [57]. This evidence concerns the gene ADAMTS9 and invasive breast carcinoma.